GEHC Stock: GE HealthCare Technologies Inc. Stock Price, Analysis & Insights
Get live gehc stock price $73.05, comprehensive GE HealthCare Technologies Inc. stock analysis, charts, news, and expert forecast. Real-time gehc stock data and investment insights.
Loading chart...
Company Overview
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Company Information
- CEO
- Peter J. Arduini
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Employees
- 53000
Contact Information
- Website
- https://www.gehealthcare.com
- Address
- 500 West Monroe Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 15.1)
✓ Higher growth potential with elevated volatility (Beta: 1.27)
Business Model & Strategy
GE HealthCare Technologies Inc. operates in the Medical - Healthcare Information Services industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Peter J. Arduini, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Healthcare Information Services model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
GE HealthCare Technologies Inc. competes in the Medical - Healthcare Information Services within the broader Healthcare. With 33.4 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Select, GE HealthCare Technologies Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating GE HealthCare Technologies Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for GE HealthCare Technologies Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for GE HealthCare Technologies Inc.
- ⚠Investors should consider how GE HealthCare Technologies Inc. fits within their overall portfolio allocation
Market Cap
33.37B
P/E Ratio
15.12
Beta
1.27
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 33.37B market capitalization
- Trading Volume: 4.35M shares traded today
- Price Range: 52-week range of $57.65 - $94.80
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. (GEHC) operates in the Medical - Healthcare Information Services industry within the Healthcare sector. With a current market capitalization of 33.37B, the company represents a significant player in its market. The stock is currently trading at $73.05 with a negativedaily change of 1.51%.
The company's 53000 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 15.12, beta of 1.27, and 52-week price range from $57.65 to $94.80when evaluating investment opportunities.
Why Invest in GE HealthCare Technologies Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Peter J. Arduini
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.